Literature DB >> 16118676

Characteristics of Achromobacter xylosoxidans bacteremia in northern Taiwan.

Shian-Sen Shie1, Ching-Tai Huang, Hsieh-Shong Leu.   

Abstract

There were 40 cases of Achromobacter xylosoxidans bacteremia during a 6-year period in a medical center in northern Taiwan. Males outnumbered females (72.5% vs 27.5%). Common underlying diseases and conditions in these 40 bacteremic patients were malignancies (57.5%), central venous catheter implants (55%), surgery (35%), neutropenia (30%) and use of steroids (25%). Recurrent bacteremia occurred in 4 patients (10%), all of whom had a central venous catheter implant which was considered the most probable source of infection. More than one-quarter (27.5%) of the cases were community acquired. The mortality rate due to A. xylosoxidans bacteremia was 47.5%. Risk factors significantly associated with mortality were nosocomial acquisition and polymicrobial bacteremia. Disk susceptibility testing showed that these isolates were resistant to aminoglycosides and most cephalosporins but were susceptible to piperacillin, imipenem, ceftazidime and trimethoprim-sulfamethoxazole.

Entities:  

Mesh:

Year:  2005        PMID: 16118676

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  11 in total

1.  Fatal catheter-related bacteremia due to Alcaligenes (Achromobacter) xylosoxidans in a hemodialysis patient.

Authors:  K Turgutalp; A Kiykim; G Ersoz; A Kaya
Journal:  Int Urol Nephrol       Date:  2011-06-03       Impact factor: 2.370

2.  Achromobacter xylosoxidans keratitis after contact lens usage.

Authors:  Jung Hyun Park; Nang Hee Song; Jae Woong Koh
Journal:  Korean J Ophthalmol       Date:  2012-01-14

3.  Pulmonary Infection Caused by Achromobacter xylosoxidans in a Patient with Carcinoma of Epiglottis: A Rare Case.

Authors:  Priyamvada Roy
Journal:  J Clin Diagn Res       Date:  2014-05-15

4.  Epidemiological typing of clinical isolates of Achromobacter xylosoxidans: comparison of phenotypic and genotypic methods.

Authors:  M Kaur; P Ray; M Bhatty; M Sharma
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-04-17       Impact factor: 3.267

5.  Achromobacter species endocarditis: A case report and literature review.

Authors:  Catherine Derber; Kara Elam; Betty A Forbes; Gonzalo Bearman
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

6.  Achromobacter causing a thrombophlebitis and osteomyelitis combination: a rare cause.

Authors:  Gizem Pamuk; Deniz Aygun; Kenan Barut; Ozgur Kasapcopur
Journal:  BMJ Case Rep       Date:  2015-09-07

7.  Complicated septic shock caused by Achromobacter xylosoxidans bacteremia in a patient with acute lymphoblastic leukaemia.

Authors:  A M Al-Jasser; K A Al-Anazi
Journal:  Libyan J Med       Date:  2007-12-01       Impact factor: 1.657

8.  A Case of Septic Shock caused by Achromobacter xylosoxidans in an Immunocompetent Female Patient after Extracorporeal Shock Wave Lithotripsy for a Ureteral Stone.

Authors:  Jae Hyuk Lee; So Yon Lee; In Young Park; So Yeon Park; Jin Seo Lee; Goeun Kang; Jae Seok Kim; Joong Sik Eom
Journal:  Infect Chemother       Date:  2016-03-31

9.  Achromobacter Xylosoxidans Bloodstream Infection in Elderly Patient with Hepatocellular Carcinoma: Case Report and Review of Literature.

Authors:  Kausalya Raghuraman; Nishat H Ahmed; Frincy K Baruah; Rajesh K Grover
Journal:  J Lab Physicians       Date:  2015 Jul-Dec

10.  Scleral buckle infection with Alcaligenes xylosoxidans.

Authors:  Chih-Kang Hsu; Yun-Hsiang Chang; Jiann-Torng Chen
Journal:  Indian J Ophthalmol       Date:  2014-06       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.